Cargando…
Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms
BACKGROUND: Interleukin‐19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin‐19 expression in, and influences on, the formation and progression of experimenta...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649236/ https://www.ncbi.nlm.nih.gov/pubmed/34459250 http://dx.doi.org/10.1161/JAHA.121.022207 |
_version_ | 1784610950643449856 |
---|---|
author | Tanaka, Hiroki Xu, Baohui Xuan, Haojun Ge, Yingbin Wang, Yan Li, Yankui Wang, Wei Guo, Jia Zhao, Sihai Glover, Keith J. Zheng, Xiaoya Liu, Shuai Inuzuka, Kazunori Fujimura, Naoki Furusho, Yuko Ikezoe, Toru Shoji, Takahiro Wang, Lixin Fu, Weiguo Huang, Jianhua Unno, Naoki Dalman, Ronald L. |
author_facet | Tanaka, Hiroki Xu, Baohui Xuan, Haojun Ge, Yingbin Wang, Yan Li, Yankui Wang, Wei Guo, Jia Zhao, Sihai Glover, Keith J. Zheng, Xiaoya Liu, Shuai Inuzuka, Kazunori Fujimura, Naoki Furusho, Yuko Ikezoe, Toru Shoji, Takahiro Wang, Lixin Fu, Weiguo Huang, Jianhua Unno, Naoki Dalman, Ronald L. |
author_sort | Tanaka, Hiroki |
collection | PubMed |
description | BACKGROUND: Interleukin‐19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin‐19 expression in, and influences on, the formation and progression of experimental AAAs. METHODS AND RESULTS: Human specimens were obtained at aneurysm repair surgery or from transplant donors. Experimental AAAs were created in 10‐ to 12‐week‐old male mice via intra‐aortic elastase infusion. Influence and potential mechanisms of interleukin‐19 treatment on AAAs were assessed via ultrasonography, histopathology, flow cytometry, and gene expression profiling. Immunohistochemistry revealed augmented interleukin‐19 expression in both human and experimental AAAs. In mice, interleukin‐19 treatment before AAA initiation via elastase infusion suppressed aneurysm formation and progression, with attenuation of medial elastin degradation, smooth‐muscle depletion, leukocyte infiltration, neoangiogenesis, and matrix metalloproteinase 2 and 9 expression. Initiation of interleukin‐19 treatment after AAA creation limited further aneurysmal degeneration. In additional experiments, interleukin‐19 treatment inhibited murine macrophage recruitment following intraperitoneal thioglycolate injection. In classically or alternatively activated macrophages in vitro, interleukin‐19 downregulated mRNA expression of inducible nitric oxide synthase, chemokine C‐C motif ligand 2, and metalloproteinases 2 and 9 without apparent effect on cytokine‐expressing helper or cytotoxic T‐cell differentiation, nor regulatory T cellularity, in the aneurysmal aorta or spleen of interleukin‐19–treated mice. Interleukin‐19 also suppressed AAAs created via angiotensin II infusion in hyperlipidemic mice. CONCLUSIONS: Based on human evidence and experimental modeling observations, interleukin‐19 may influence the development and progression of AAAs. |
format | Online Article Text |
id | pubmed-8649236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86492362022-01-14 Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms Tanaka, Hiroki Xu, Baohui Xuan, Haojun Ge, Yingbin Wang, Yan Li, Yankui Wang, Wei Guo, Jia Zhao, Sihai Glover, Keith J. Zheng, Xiaoya Liu, Shuai Inuzuka, Kazunori Fujimura, Naoki Furusho, Yuko Ikezoe, Toru Shoji, Takahiro Wang, Lixin Fu, Weiguo Huang, Jianhua Unno, Naoki Dalman, Ronald L. J Am Heart Assoc Original Research BACKGROUND: Interleukin‐19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin‐19 expression in, and influences on, the formation and progression of experimental AAAs. METHODS AND RESULTS: Human specimens were obtained at aneurysm repair surgery or from transplant donors. Experimental AAAs were created in 10‐ to 12‐week‐old male mice via intra‐aortic elastase infusion. Influence and potential mechanisms of interleukin‐19 treatment on AAAs were assessed via ultrasonography, histopathology, flow cytometry, and gene expression profiling. Immunohistochemistry revealed augmented interleukin‐19 expression in both human and experimental AAAs. In mice, interleukin‐19 treatment before AAA initiation via elastase infusion suppressed aneurysm formation and progression, with attenuation of medial elastin degradation, smooth‐muscle depletion, leukocyte infiltration, neoangiogenesis, and matrix metalloproteinase 2 and 9 expression. Initiation of interleukin‐19 treatment after AAA creation limited further aneurysmal degeneration. In additional experiments, interleukin‐19 treatment inhibited murine macrophage recruitment following intraperitoneal thioglycolate injection. In classically or alternatively activated macrophages in vitro, interleukin‐19 downregulated mRNA expression of inducible nitric oxide synthase, chemokine C‐C motif ligand 2, and metalloproteinases 2 and 9 without apparent effect on cytokine‐expressing helper or cytotoxic T‐cell differentiation, nor regulatory T cellularity, in the aneurysmal aorta or spleen of interleukin‐19–treated mice. Interleukin‐19 also suppressed AAAs created via angiotensin II infusion in hyperlipidemic mice. CONCLUSIONS: Based on human evidence and experimental modeling observations, interleukin‐19 may influence the development and progression of AAAs. John Wiley and Sons Inc. 2021-08-28 /pmc/articles/PMC8649236/ /pubmed/34459250 http://dx.doi.org/10.1161/JAHA.121.022207 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Tanaka, Hiroki Xu, Baohui Xuan, Haojun Ge, Yingbin Wang, Yan Li, Yankui Wang, Wei Guo, Jia Zhao, Sihai Glover, Keith J. Zheng, Xiaoya Liu, Shuai Inuzuka, Kazunori Fujimura, Naoki Furusho, Yuko Ikezoe, Toru Shoji, Takahiro Wang, Lixin Fu, Weiguo Huang, Jianhua Unno, Naoki Dalman, Ronald L. Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms |
title | Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms |
title_full | Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms |
title_fullStr | Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms |
title_full_unstemmed | Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms |
title_short | Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms |
title_sort | recombinant interleukin‐19 suppresses the formation and progression of experimental abdominal aortic aneurysms |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649236/ https://www.ncbi.nlm.nih.gov/pubmed/34459250 http://dx.doi.org/10.1161/JAHA.121.022207 |
work_keys_str_mv | AT tanakahiroki recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT xubaohui recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT xuanhaojun recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT geyingbin recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT wangyan recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT liyankui recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT wangwei recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT guojia recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT zhaosihai recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT gloverkeithj recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT zhengxiaoya recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT liushuai recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT inuzukakazunori recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT fujimuranaoki recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT furushoyuko recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT ikezoetoru recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT shojitakahiro recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT wanglixin recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT fuweiguo recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT huangjianhua recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT unnonaoki recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms AT dalmanronaldl recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms |